Radiopharm Theranostics LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Lantheus Holdings, through its subsidiaries, has disclosed a significant beneficial ownership of 20.9% in Radiopharm Theranostics Limited, detailing strategic investments and co-development partnerships.